Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The History section now shows revision v3.6.4, replacing v3.6.3. This indicates a new version of the record/history was published, updating the page's underlying revision metadata.
    Difference
    0.1%
    Check dated 2026-07-27T05:55:05.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The revision label in the history table updates from v3.6.2 to v3.6.3, indicating a new revision of the study record.
    Difference
    0.1%
    Check dated 2026-07-05T11:46:50.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page history now lists Revision: v3.6.2, replacing v3.6.0. This reflects a small update to the page’s versioning rather than a change to the study data or visible content.
    Difference
    0.1%
    Check dated 2026-06-28T08:39:00.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study record now indicates that no more participants are being recruited. The record has been updated to version v3.6.0, replacing the prior revision.
    Difference
    0.3%
    Check dated 2026-06-14T06:18:34.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The version history now displays a new revision entry (v3.5.5) and removes the preceding revision (v3.5.4), reflecting an updated record meta.
    Difference
    0.1%
    Check dated 2026-06-07T03:41:33.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Record History now includes added sections for Adverse Events, Outcome Measures, Participant Flow, and References. A new version entry dated 2026-05-12 indicates updated content in the study record.
    Difference
    0.8%
    Check dated 2026-05-16T09:21:17.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.